RxDoctor Payments Data

Sonal Sinha, MD

Psychiatry · Mansfield, OHNPI 1336495258

Payments from drug & device makers

$738in general payments, 2019–2025

Across 46 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$278
  • AbbVie$146
  • Alkermes, Inc.$64
  • Axsome Therapeutics, Inc.$59
  • Vanda Pharmaceuticals Inc.$52
  • Indivior Inc.$22
  • plus $116 from 7 others

What the payments were for

  • Food & beverage$72598%
  • Education$132%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$738 in reported general payments places this provider in the 65th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$66,052
Medicare patients
81
Services billed
634

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate100$299,398
IngrezzaValbenazine Tosylate23$193,693
Abilify MaintenaAripiprazole45$127,953
VraylarCariprazine Hcl51$80,040
PerserisRisperidone20$58,649
FanaptIloperidone12$41,566
LybalviOlanzapine/Samidorphan Malate11$34,252
RexultiBrexpiprazole22$32,865
Risperdal ConstaRisperidone Microspheres27$32,844
Austedo XrDeutetrabenazine11$24,704
Aripiprazole273$20,014
TrintellixVortioxetine Hydrobromide22$17,212
Atomoxetine Hcl40$11,325
Ziprasidone Hcl129$10,034
Divalproex Sodium ErDivalproex Sodium150$9,766

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$19$332,242127 claims
Neurocrine Biosciences, Inc.Ingrezza$18$193,69323 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$278$160,81767 claims
AbbVieVraylar$146$80,04051 claims
Indivior Inc.Perseris$22$58,64920 claims
Vanda Pharmaceuticals Inc.Fanapt$52$41,56612 claims
Alkermes, Inc.Lybalvi$64$34,25211 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$16$24,70411 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$15$17,21222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Mansfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →